153 related articles for article (PubMed ID: 27495042)
1. Significant partial response of metastatic intra-abdominal and pelvic round cell liposarcoma to a small-molecule VEGFR-2 tyrosine kinase inhibitor apatinib: A case report.
Dong M; Bi J; Liu X; Wang B; Wang J
Medicine (Baltimore); 2016 Aug; 95(31):e4368. PubMed ID: 27495042
[TBL] [Abstract][Full Text] [Related]
2. Successful treatment of advanced pancreatic liposarcoma with apatinib: A case report and literature review.
Han T; Luan Y; Xu Y; Yang X; Li J; Liu R; Li Q; Zheng Z
Cancer Biol Ther; 2017 Sep; 18(9):635-639. PubMed ID: 28678611
[TBL] [Abstract][Full Text] [Related]
3. Effective treatment of apatinib in desmoplastic small round cell tumor: a case report and literature review.
Shi C; Feng Y; Zhang LC; Ding DY; Yan MY; Pan L
BMC Cancer; 2018 Mar; 18(1):338. PubMed ID: 29587657
[TBL] [Abstract][Full Text] [Related]
4. Effective apatinib treatment of pleomorphic liposarcoma: A case report.
Yan P; Sun ML; Sun YP; Liu CY
Medicine (Baltimore); 2017 Aug; 96(33):e7771. PubMed ID: 28816958
[TBL] [Abstract][Full Text] [Related]
5. Treatment of consistent BRAF/HRAS gene mutation and MYC amplification radiation-induced abdominal wall angiosarcoma with low-dose apatinib: a case report.
Guan J; Luo Z; Xiao Z; Xie Y; Lin L
BMC Cancer; 2019 Dec; 19(1):1188. PubMed ID: 31805975
[TBL] [Abstract][Full Text] [Related]
6. Apatinib: A Review in Advanced Gastric Cancer and Other Advanced Cancers.
Scott LJ
Drugs; 2018 May; 78(7):747-758. PubMed ID: 29663291
[TBL] [Abstract][Full Text] [Related]
7. Apatinib for the treatment of gastric cancer.
Geng R; Li J
Expert Opin Pharmacother; 2015 Jan; 16(1):117-22. PubMed ID: 25420417
[TBL] [Abstract][Full Text] [Related]
8. Extraordinary response of metastatic pancreatic cancer to apatinib after failed chemotherapy: A case report and literature review.
Li CM; Liu ZC; Bao YT; Sun XD; Wang LL
World J Gastroenterol; 2017 Nov; 23(41):7478-7488. PubMed ID: 29151702
[TBL] [Abstract][Full Text] [Related]
9. A case report of apatinib in treating osteosarcoma with pulmonary metastases.
Zhou Y; Zhang W; Tang F; Luo Y; Min L; Zhang W; Shi R; Duan H; Tu C
Medicine (Baltimore); 2017 Apr; 96(15):e6578. PubMed ID: 28403086
[TBL] [Abstract][Full Text] [Related]
10. Apatinib and S-1 combination therapy for the treatment of advanced head and neck neoplasms: Three case reports.
Meng M; Ye X; Yang X; Huang G; Wei Z; Ni Y; Li W; Han X; Wang J
J Cancer Res Ther; 2019; 15(2):442-446. PubMed ID: 30964124
[TBL] [Abstract][Full Text] [Related]
11. Use of apatinib combined with pemetrexed for advanced ovarian cancer: A case report.
Sun H; Xiao M; Liu S; Shi R
Medicine (Baltimore); 2018 Jul; 97(27):e11036. PubMed ID: 29979376
[TBL] [Abstract][Full Text] [Related]
12. Low dosage of apatinib monotherapy as rescue treatment in advanced lung squamous cell carcinoma.
Zeng DX; Lei W; Wang CG; Huang JA; Jiang JH
Cancer Chemother Pharmacol; 2019 Mar; 83(3):439-442. PubMed ID: 30547193
[TBL] [Abstract][Full Text] [Related]
13. The efficacy and safety of low-dose Apatinib in the management of stage IV luminal-type breast cancer: a case report and literature review.
Lv X; Chen J; Yi T; Lu H; Liu J; Yu D
Anticancer Drugs; 2021 Sep; 32(8):773-778. PubMed ID: 34145174
[TBL] [Abstract][Full Text] [Related]
14. The ACTIVE study protocol: apatinib or placebo plus gefitinib as first-line treatment for patients with EGFR-mutant advanced non-small cell lung cancer (CTONG1706).
Zhang Z; Luo F; Zhang Y; Ma Y; Hong S; Yang Y; Fang W; Huang Y; Zhang L; Zhao H
Cancer Commun (Lond); 2019 Nov; 39(1):69. PubMed ID: 31699150
[TBL] [Abstract][Full Text] [Related]
15. Response to apatinib in chemotherapy-failed advanced spindle cell breast carcinoma.
Zhou N; Liu C; Hou H; Zhang C; Liu D; Wang G; Liu K; Zhu J; Lv H; Li T; Zhang X
Oncotarget; 2016 Nov; 7(44):72373-72379. PubMed ID: 27738308
[TBL] [Abstract][Full Text] [Related]
16. A Pilot Study of Apatinib as Third-Line Treatment in Patients With Heavily Treated Metastatic Colorectal Cancer.
Liang L; Wang L; Zhu P; Xia Y; Qiao Y; Wu J; Zhuang W; Fei J; Wen Y; Jiang X
Clin Colorectal Cancer; 2018 Sep; 17(3):e443-e449. PubMed ID: 29576426
[TBL] [Abstract][Full Text] [Related]
17. The safety of apatinib for the treatment of gastric cancer.
Geng R; Song L; Li J; Zhao L
Expert Opin Drug Saf; 2018 Nov; 17(11):1145-1150. PubMed ID: 30324820
[TBL] [Abstract][Full Text] [Related]
18. Successful treatment using apatinib with or without docetaxel in heavily pretreated advanced non-squamous non-small cell lung cancer: A case report and literature review.
Wu F; Zhang S; Gao G; Zhao J; Ren S; Zhou C
Cancer Biol Ther; 2018 Mar; 19(3):141-144. PubMed ID: 29261000
[TBL] [Abstract][Full Text] [Related]
19. The use of apatinib in treating primary pleural synovial sarcoma: A case report.
Chen S; Zhang K; Wan X; Chen Y; Ma S; Deng Q
Medicine (Baltimore); 2019 Dec; 98(51):e18382. PubMed ID: 31861000
[TBL] [Abstract][Full Text] [Related]
20. Successful treatment using apatinib in intractable brain edema: A case report and literatures review.
Song Y; Liu B; Guan M; Liu M
Cancer Biol Ther; 2018; 19(12):1093-1096. PubMed ID: 30081717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
